Joseph DosSantos

Acting Chief Financial Officer at Defender Pharmaceuticals, Inc
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Defender Pharmaceuticals, Inc
    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Acting Chief Financial Officer
      • Jan 2023 - Present

      St. Louis City County, Missouri, United States Clinical stage biopharmaceutical company developing a novel internasal scopolamine technology for several indications.

  • Luzsana Biotechnology
    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Chief Financial Officer | CFO
      • Aug 2021 - Sep 2022

      Princeton, New Jersey, United States Wholly owned subsidiary of Jiangsu Hengrui Pharmaceuticals focused on co-developing a pipeline of innovative medicines for ex-China markets.

  • Celularity Inc.
    • United States
    • Biotechnology
    • 100 - 200 Employee
    • Senior Vice President Finance | SVP
      • 2017 - Aug 2021

      Warren, NJ Biotechnology company formed from the spin-out of Celgene’s Cellular Therapeutics Division focused on productizing allogeneic cells and tissues derived from the postpartum placenta.

  • MYOS CORP
    • United States
    • Manufacturing
    • 1 - 100 Employee
    • Chief Financial Officer | CFO
      • 2014 - 2016

      Cedar Knolls, NJ NASDAQ listed biotech focused on discovery & development of products to improve muscle health and function.

  • Allergan
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Executive Director, Finance Operations
      • 2011 - 2014

      Parsippany, NJ (previously Actavis plc) Global specialty pharmaceutical company engaged in the development, manufacturing, marketing, sale, and distribution of generic, brand and over the counter (OTC) pharmaceutical products.

  • Celgene
    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Sr. Director, Assistant Corporate Controller
      • 2003 - 2010

      Global biopharmaceutical company engaged in the discovery, development and commercialization of cancer and immune-inflammatory disease treatments.

  • Cytec Solvay Group
    • Chemical Manufacturing
    • 700 & Above Employee
    • Sr. Manager, SEC Reporting
      • 1998 - 2003

  • National Starch & Chemical Company
    • Sr. Accountant
      • 1991 - 1998

      Bridgewater, NJ

Education

  • Seton Hall University
    MBA, Finance

Community

You need to have a working account to view this content. Click here to join now